TECX
Tectonic Therapeutic Inc.

2,198
Mkt Cap
$372.83M
Volume
251,443.00
52W High
$61.07
52W Low
$13.70
PE Ratio
-5.17
TECX Fundamentals
Price
$19.92
Prev Close
$20.98
Open
$20.99
50D MA
$17.92
Beta
1.34
Avg. Volume
447,205.84
EPS (Annual)
-$6.83
P/B
1.31
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
Tectonic Therapeutic, Inc. (NASDAQ:TECX) Receives Consensus Rating of "Moderate Buy" from Brokerages
Tectonic Therapeutic, Inc. (NASDAQ:TECX - Get Free Report) has earned a consensus rating of "Moderate Buy" from the seven ratings firms that are currently covering the firm, MarketBeat.com reports...
MarketBeat·5d ago
News Placeholder
More News
News Placeholder
Tectonic Therapeutic (NASDAQ:TECX) Issues Earnings Results, Beats Estimates By $0.03 EPS
Tectonic Therapeutic (NASDAQ:TECX - Get Free Report) announced its quarterly earnings data on Thursday. The company reported ($1.02) EPS for the quarter, beating analysts' consensus estimates of...
MarketBeat·29d ago
News Placeholder
Why Tectonic Therapeutic Stock Soared 30% After-Hours Today
Stocktwits·1mo ago
News Placeholder
Tectonic Stock Soars Pre-market After Tuesday’s Sell-Off: Oppenheimer Is Hopeful About Company’s Lead Candidate
Oppenheimer stated that it likes the prospects of Tectonic's lead asset, TX45, to address prevalent and progressive cardiovascular disorders that are inadequately treated.
Stocktwits·3mo ago
News Placeholder
Raymond James bullish on biotech firms on favorable valuation
Investing.com -- Raymond James started coverage on biotechnology companies, rating Avidity Biosciences and Disc Medicine at Strong Buy and assigning Outperform ratings to Dyne Therapeutics, Tectonic Therapeutic, and Wave Life Sciences (NASDAQ:WVE), pointing to a sector-wide opportunity amid “suppressed valuations.”
investing.com·6mo ago
News Placeholder
Wall Street Analysts See a 258.52% Upside in Tectonic Therapeutic, Inc. (TECX): Can the Stock Really Move This High?
Zacks·7mo ago
News Placeholder
Buy Rating Affirmed on Tectonic Therapeutics' TX45 for Promising Clinical Advancements
TD Cowen analyst Tyler Van Buren has maintained their bullish stance on TECX stock, giving a Buy rating on July 30. Tyler Van Buren has given his B...
TipRanks Financial Blog·1y ago
News Placeholder
Tectonic Therapeutic Announces COO Departure and Severance Terms
Tectonic Therapeutic (TECX) has shared an announcement. Tectonic Therapeutic, Inc. has reached a separation agreement with its COO, Dr. Christian C...
TipRanks Financial Blog·1y ago

Latest TECX News

View

Advertisement|Remove ads.

Advertisement|Remove ads.